Home Journal Club	FAQ My Amedeo About	Flying Publisher
Publish	FPG #4: Hepatitis C Treatment (free PDF) FPG #5: La Plagiocefalia Posizionale (Italian, free PDF)

Liver Cirrhosis

Free Subscription Articles published in Am J Gastroenterol Retrieve available abstracts of 50 articles: HTML format Text format

Single Articles

September 2011
1. KIM BK , Kim do Y, Han KH, Park JY, et al
   Erratum: risk assessment of esophageal variceal bleeding in B-viral liver cirrhosis by a liver stiffness measurement-based model.
   Am J Gastroenterol. 2011;106:1730.
   PubMed     Text format     Related articles   
   
   
   
2. RAFTOPOULOS SC , Efthymiou M, May G, Marcon N, et al
   Dysplastic Barrett's Esophagus in Cirrhosis: A Treatment Dilemma.
   Am J Gastroenterol. 2011;106:1724-6.
   PubMed     Text format     Related articles   
   
   
   
3. DOGANAY L , Kiziltas S, Colak Y, Gulluoglu M, et al
   Is the lymphoma risk reduced in viral hepatitis? A cirrhotic patient with triple malignancies.
   Am J Gastroenterol. 2011;106:1719-20.
   PubMed     Text format     Related articles   
   
   
   July 2011
4. BERMAN K , Tandra S, Vuppalanch R, Ghabril M, et al
   Hepatic and extrahepatic cancer in cirrhosis: a longitudinal cohort study.
   Am J Gastroenterol. 2011;106:1405.
   PubMed     Text format     Related articles   
   
   
   June 2011
5. KIM BK , Kim DY, Han KH, Park JY, et al
   Risk Assessment of Esophageal Variceal Bleeding in B-Viral Liver Cirrhosis by a Liver Stiffness Measurement-Based Model.
   Am J Gastroenterol. 2011 Jun 21. doi: 10.1038/ajg.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
6. SAVARINO E , Assandri L, Giannini EG, Savarino V, et al
   Small Intestinal Bacterial Overgrowth and Helicobacter pylori: Can They Be Cause of Thrombocytopenia in Patients With Chronic Liver Disease?
   Am J Gastroenterol. 2011;106:1171-2.
   PubMed     Text format     Related articles   
   
   
   May 2011
7. BAJAJ JS , Wade JB, Gibson DP, Heuman DM, et al
   The Multi-Dimensional Burden of Cirrhosis and Hepatic Encephalopathy on Patients and Caregivers.
   Am J Gastroenterol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   April 2011
8. MONTOLIU C , Cauli O, Urios A, Elmlili N, et al
   3-Nitro-Tyrosine as a Peripheral Biomarker of Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis.
   Am J Gastroenterol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   March 2011
9. TALWALKAR JA
   Evening administration of long-acting Beta-blockers for primary prophylaxis in cirrhosis: an effective strategy.
   Am J Gastroenterol. 2011;106:545.
   PubMed     Text format     Related articles   
   
   
   
10. CONJEEVARAM HS , Tiniakos DG
    Editorial: Exercise for NAFLD: does intensity matter?
    Am J Gastroenterol. 2011;106:470-5.
    PubMed     Text format     Related articles   
    
    
    
11. KISTLER KD , Brunt EM, Clark JM, Diehl AM, et al
    Physical activity recommendations, exercise intensity, and histological severity of nonalcoholic fatty liver disease.
    Am J Gastroenterol. 2011;106:460-8.
    PubMed     Text format     Related articles   
    
    
    February 2011
12. LES I , Doval E, Garcia-Martinez R, Planas M, et al
    Effects of Branched-Chain Amino Acids Supplementation in Patients With Cirrhosis and a Previous Episode of Hepatic Encephalopathy: A Randomized Study.
    Am J Gastroenterol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
13. BUTTERWORTH RF
    Editorial: rifaximin and minimal hepatic encephalopathy.
    Am J Gastroenterol. 2011;106:317-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2011
14. HUANG Y , Lok AS
    Viral factors and outcomes of chronic HBV infection.
    Am J Gastroenterol. 2011;106:93-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
15. LIAO WC , Hou MC, Chang CJ, Lee FY, et al
    Potential precipitating factors of esophageal variceal bleeding: a case-control study.
    Am J Gastroenterol. 2011;106:96-103.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2010
16. BERMAN K , Tandra S, Vuppalanch R, Ghabril M, et al
    Hepatic and Extrahepatic Cancer in Cirrhosis: A Longitudinal Cohort Study.
    Am J Gastroenterol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
17. SIDHU SS , Goyal O, Mishra BP, Sood A, et al
    Rifaximin Improves Psychometric Performance and Health-Related Quality of Life in Patients With Minimal Hepatic Encephalopathy (The RIME Trial).
    Am J Gastroenterol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
18. FONTANA RJ , Sanyal AJ, Ghany MG, Bonkovsky HL, et al
    Development and Progression of Portal Hypertensive Gastropathy in Patients With Chronic Hepatitis C.
    Am J Gastroenterol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
19. KALAMBOKIS G , Tsianos EV
    Thrombocytopenia associated with chronic liver disease: effects of rifaximin on platelet count.
    Am J Gastroenterol. 2010;105:2705-7.
    PubMed     Text format     Related articles   
    
    
    October 2010
20. YIN J , Xie J, Liu S, Zhang H, et al
    Association Between the Various Mutations in Viral Core Promoter Region to Different Stages of Hepatitis B, Ranging of Asymptomatic Carrier State to Hepatocellular Carcinoma.
    Am J Gastroenterol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
21. NOUREDDIN M , Ghany MG
    Editorial: Treatment of patients with HCV-related cirrhosis with peginterferon and ribavirin: Swinging the pendulum toward treatment.
    Am J Gastroenterol. 2010;105:2174-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2010
22. FERNANDEZ-RODRIGUEZ CM , Alonso S, Martinez SM, Forns X, et al
    Peginterferon Plus Ribavirin and Sustained Virological Response in HCV-Related Cirrhosis: Outcomes and Factors Predicting Response.
    Am J Gastroenterol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2010
23. KUMAGI T , Guindi M, Fischer SE, Arenovich T, et al
    Baseline Ductopenia and Treatment Response Predict Long-Term Histological Progression in Primary Biliary Cirrhosis.
    Am J Gastroenterol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    April 2010
24. BALART LA , Lisker-Melman M, Hamzeh FM, Kwok A, et al
    Peginterferon alpha-2a Plus Ribavirin in Latino and Non-Latino Whites With HCV Genotype 1: Histologic Outcomes and Tolerability From the LATINO Study.
    Am J Gastroenterol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    March 2010
25. MONTAGNESE S , Middleton B, Mani AR, Skene DJ, et al
    On the Origin and the Consequences of Circadian Abnormalities in Patients With Cirrhosis.
    Am J Gastroenterol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    February 2010
26. NUNES D , Fleming C, Offner G, Craven D, et al
    Noninvasive Markers of Liver Fibrosis Are Highly Predictive of Liver-Related Death in a Cohort of HCV-Infected Individuals With and Without HIV Infection.
    Am J Gastroenterol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
27. RIGGIO O , Mannaioni G, Ridola L, Angeloni S, et al
    Peripheral and Splanchnic Indole and Oxindole Levels in Cirrhotic Patients: A Study on the Pathophysiology of Hepatic Encephalopathy.
    Am J Gastroenterol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
28. QI X , Han G, Wu K, Fan D, et al
    A confusing relationship between child-turcotte-pugh class a and compensated cirrhosis.
    Am J Gastroenterol. 2010;105:470-2.
    PubMed     Text format     Related articles   
    
    
    
29. SORRENTINO P , Terracciano L, D'Angelo S, Ferbo U, et al
    Predicting fibrosis worsening in obese patients with NASH through parenchymal fibronectin, HOMA-IR, and hypertension.
    Am J Gastroenterol. 2010;105:336-44.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2010
30. FONTANA RJ , Bieliauskas LA, Back-Madruga C, Lindsay KL, et al
    Cognitive Function Does Not Worsen During Long-Term Low-Dose Peginterferon Therapy in Patients With Chronic Hepatitis C.
    Am J Gastroenterol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
31. KIM BK , Han KH, Park JY, Ahn SH, et al
    A Liver Stiffness Measurement-Based, Noninvasive Prediction Model for High-Risk Esophageal Varices in B-Viral Liver Cirrhosis.
    Am J Gastroenterol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
32. IOANNOU GN
    Cholelithiasis, Cholecystectomy, and Liver Disease.
    Am J Gastroenterol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
33. EFE C , Purnak T, Ozaslan E, Wahlin S, et al
    The serological profile of the autoimmune hepatitis/primary biliary cirrhosis overlap syndrome.
    Am J Gastroenterol. 2010;105:226.
    PubMed     Text format     Related articles   
    
    
    
34. MONTAGNESE S , Middleton B, Mani AR, Skene DJ, et al
    Melatonin rhythms in patients with cirrhosis.
    Am J Gastroenterol. 2010;105:220-2.
    PubMed     Text format     Related articles   
    
    
    
35. GARCIA-TSAO G , Surawicz CM
    Editorial: Clostridium difficile infection: Yet another predictor of poor outcome in cirrhosis.
    Am J Gastroenterol. 2010;105:114-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2009
36. SENZOLO M , Fries W, Buda A, Pizzuti D, et al
    Oral propranolol decreases intestinal permeability in patients with cirrhosis: another protective mechanism against bleeding?
    Am J Gastroenterol. 2009;104:3115-6.
    PubMed     Text format     Related articles   
    
    
    November 2009
37. FUNG J , Lai CL, Chan SC, But D, et al
    Correlation of Liver Stiffness and Histological Features in Healthy Persons and in Patients With Occult Hepatitis B, Chronic Active Hepatitis B, or Hepatitis B Cirrhosis.
    Am J Gastroenterol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
38. BERZIGOTTI A , Bellot P, De Gottardi A, Garcia-Pagan JC, et al
    NCX-1000, a Nitric Oxide-Releasing Derivative of UDCA, Does Not Decrease Portal Pressure in Patients With Cirrhosis: Results of a Randomized, Double-Blind, Dose-Escalating Study.
    Am J Gastroenterol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
39. DHANASEKARAN R , West JK, Gonzales PC, Subramanian R, et al
    Transjugular Intrahepatic Portosystemic Shunt for Symptomatic Refractory Hepatic Hydrothorax in Patients With Cirrhosis.
    Am J Gastroenterol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
40. NEUHAUSER M , Bjornsson E, Treeprasertsuk S, Enders F, et al
    Autoimmune Hepatitis-PBC Overlap Syndrome: A Simplified Scoring System May Assist in the Diagnosis.
    Am J Gastroenterol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2009
41. GRANITO A , Yang WH, Muratori L, Lim MJ, et al
    PML Nuclear Body Component Sp140 Is a Novel Autoantigen in Primary Biliary Cirrhosis.
    Am J Gastroenterol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
42. BAJAJ JS , Ananthakrishnan AN, Hafeezullah M, Zadvornova Y, et al
    Clostridium difficile Is Associated With Poor Outcomes in Patients With Cirrhosis: A National and Tertiary Center Perspective.
    Am J Gastroenterol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
43. SCARPELLINI E , Valenza V, Gabrielli M, Lauritano EC, et al
    Intestinal Permeability in Cirrhotic Patients With and Without Spontaneous Bacterial Peritonitis: Is the Ring Closed?
    Am J Gastroenterol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
44. WONG VW , Wong GL, Yu J, Choi PC, et al
    Interaction of Adipokines and Hepatitis B Virus on Histological Liver Injury in the Chinese.
    Am J Gastroenterol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2009
45. KRISHNA S , Rose J, Jambhekar K, Olden K, et al
    Cirrhosis of liver and an unusual ectopic site of portosystemic shunt: left adnexal venous varix presenting with hematuria.
    Am J Gastroenterol. 2009;104:2365-6.
    PubMed     Text format     Related articles   
    
    
    
46. CAREY W
    A balancing view: Should cirrhotic patients with small esophageal varices undergo primary bleeding prophylaxis?
    Am J Gastroenterol. 2009;104:2136-8.
    PubMed     Text format     Related articles   
    
    
    
47. TALWALKAR JA
    Con: Primary prophylaxis for patients with small esophageal varices from cirrhosis: let the buyer beware.
    Am J Gastroenterol. 2009;104:2134-6.
    PubMed     Text format     Related articles   
    
    
    
48. GIANNINI EG
    Pro: Cirrhotic patients with small esophageal varices should undergo primary prophylaxis.
    Am J Gastroenterol. 2009;104:2132-4.
    PubMed     Text format     Related articles   
    
    
    
49. YNDESTAD A , Haukeland JW, Dahl TB, Bjoro K, et al
    A complex role of activin A in non-alcoholic fatty liver disease.
    Am J Gastroenterol. 2009;104:2196-205.
    PubMed     Text format     Related articles    Abstract available
    
    
    March 2009
50. ELSAMMAN MK , Fujiwara Y, Kameda N, Okazaki H, et al
    Predictive Factors of Worsening of Esophageal Varices After Balloon-Occluded Retrograde Transvenous Obliteration in Patients With Gastric Varices.
    Am J Gastroenterol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: